DNA Metabolism in Mycobacterium tuberculosis: Implications for Drug Resistance and Strain Variability

References

• Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 1998; 79: 3–29.
   PubMedGoogle Scholar
• Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, Whittam TS, et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci USA 1997; 94: 9869–74.
   PubMed Web of Science ®Google Scholar
• Musser JM, Amin A, Ramaswamy S. Negligible genetic diversity of Mycobacterium tuberculosis host immune system protein targets. Evidence of limited selective pressure. Genetics 2000; 155: 7–16.
   Google Scholar
• David HL, Newman CM. Some observations on the genetics of isoniazid resistance in the tubercle bacilli. Am Rev Respir Dis 1971; 104: 508–15.
   PubMedGoogle Scholar
• Metzgar D, Wills C. Evidence for the adaptive evolution of mutation rates. Cell 2000; 101: 581–4.
   PubMed Web of Science ®Google Scholar
• Mizrahi V, Andersen SJ. DNA repair in Mycobacterium tuberculosis. What have we learnt from the genome sequence? Mol Microbiol 1998; 29: 1331–9.
   Google Scholar
• Nyka W. Method for staining both acid-fast and chromophobic tubercle bacilli with carbolfuschin. J Bacteriol 1967; 93: 1458–60.
   PubMed Web of Science ®Google Scholar
• Nyka W. Studies on the effects of starvation on mycobacteria. Infect Immun 1974; 9: 843–50.
   PubMedGoogle Scholar
• Wayne LG, Hayes LG. Nitrate reduction as a marker for hypoxic shiftdown of Mycobacterium tuberculosis. Tuber Lung Dis 1998; 79: 127–32.
   PubMedGoogle Scholar
• Weber I, Fritz C, Ruttkowski S, Kreft A, Bange FC. Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice. Mol Microbiol 2000; 35: 1017–25.
   Google Scholar
• Fritz C, Ruttkowski S, Weber I, Ackermann B, Jost I, Bange FC. Nitrate respiration is essential for growth but not persistence of M. bovis. In: Abstracts of the ASM Conference on Tuberculosis: Past, Present and Future, New York June 20–24. Washington, D.C.: American Society for Microbiology Press, 2000: Abstract 139.
   Google Scholar
• Brons HJ, Hagen WR, Zehnder AJ. Ferrous iron dependent nitric oxide production in nitrate reducing cultures of Escherichia coli. Arch Microbiol 1991; 155: 341–7.
   Google Scholar
• Garbe TR, Hibler NS, Deretic V. Response of Mycobacterium tuberculosis to reactive oxygen and nitrogen intermediates. Mol Med 1996; 2: 134–42.
   Google Scholar
• Garbe TR, Hibler NS, Deretic V. Response to reactive nitrogen intermediates in Mycobacterium tuberculosis: induction of the 16-kilodalton alpha-crystallin homolog by exposure to nitric oxide donors. Infect Immun 1999; 67: 460–5.
   Google Scholar
• Ehrt S, Shiloh MU, Ruan J, Choi M, Gunzburg S, Nathan C, et al. A novel antioxidant gene from Mycobacterium tuberculosis. J Exp Med 1998; 186: 1885–96.
   Google Scholar
• Hu Y, Butcher PD, Mangan JA, Rajandream MA, Coates AR. Regulation of hmp gene transcription in Mycobacterium tuberculosis: effects of oxygen limitation and nitrosative and oxidative stress. J Bacteriol 1999; 181: 3486–93.
   Google Scholar
• Ruan J, St John G, Ehrt S, Riley L, Nathan C. noxR3, a novel gene from Mycobacterium tuberculosis protects Salmonella typhimurium from nitrosative and oxidative stress. Infect Immun 1999; 67: 3276–83.
   PubMed Web of Science ®Google Scholar
• Wayne LG, Hayes LG. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 1996; 64: 2062–9.
   PubMed Web of Science ®Google Scholar
• Hu YM, Butcher PD, Sole K, Mitchison DA, Coates AR. Protein synthesis is shut down in dormant Mycobacterium tuberculosis and is reversed by oxygen or heat shock. FEMS Microbiol Lett 1998; 158: 139–45.
   Google Scholar
• Foster JW, Moreno M. Inducible acid tolerance mechanisms in enteric bacteria. Novartis Found Symp 1999; 221: 55–74.
   PubMedGoogle Scholar
• Taverna P, Sedgwick B. Generation of an endogenous DNA-methylating agent by nitrosation in Escherichia coli. J Bacteriol 1996; 178: 5105–11.
   PubMedGoogle Scholar
• Sherman DR, Sabo PJ, Hickey MJ, Arain TM, Mahairas GG, Yuan Y, et al. Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria. Proc Natl Acad Sci USA 1995; 92: 6625–9.
   PubMedGoogle Scholar
• Deretic V, Phillip W, Dhandayuthapani S, Mudd MH, Curcic R, Garbe T, et al. Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid. Mol Microbiol 1995; 17: 889–900.
   PubMed Web of Science ®Google Scholar
• Deretic V, Song J, Pagan-Ramos E. Loss of oxy R in Mycobacterium tuberculosis. Trends Microbiol 1997; 5: 367–72.
   Google Scholar
• Dussurget O, Smith I. Interdependence of mycobacterial iron regulation, oxidative stress response and isonaizid resistance. Trends Microbiol 1998; 6: 354–8.
   PubMedGoogle Scholar
• Wieles B, Nagai S, Wiker HG, Harboe M, Ottenhoff TH. Identification and functional characterization of thioredoxin of Mycobacterium tuberculosis. Infect Immun 1995; 63: 4946–8.
   PubMedGoogle Scholar
• Weldingh K, Rosenkrands I, Jacobsen S, Rasmussen PB, Elhay MJ, Andersen P. Two-dimensional electrophoresis for analysis of Mycobacterium tuberculosis culture filtrate and purification and characterization of six novel proteins. Infect Immun 1998; 66: 3492–500.
   PubMedGoogle Scholar
• Harth G, Horwitz MA. Export of recombinant Mycobacterium tuberculosis superoxide dismutase is dependent upon both information in the protein and mycobacterial export machinery. A model for studying export of leaderless proteins by pathogenic mycobacteria. J Biol Chem 1999; 274: 4281–92.
   Google Scholar
• Wayne LG. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur J Clin Microbiol Infect Dis 1994; 13: 908–14.
   PubMed Web of Science ®Google Scholar
• Barry CE III, Mdluli K. Drug sensitivity and environmental adaptation of mycobacterial cell wall components. Trends Microbiol. 1996; 4: 275–81.
   PubMedGoogle Scholar
• Manca C, Paul S, Barry CE III, Freedman VH, Kaplan G. Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect Immun 1999; 67: 74–9.
   Google Scholar
• Mulder MA, Zappe H, Steyn LM. The Mycobacterium tuberculosis katG promoter region contains a novel upstream activator. Microbiology 1999; 145: 2507–18.
   Google Scholar
• Bridges BA. The role of DNA damage in stationary phase (‘‘adaptive’’) mutation. Mut Res 1998; 408: 1–9.
   PubMedGoogle Scholar
• Cox MM, Goodman MF, Kreuzer KN, Sherratt DJ, Sandler SJ, Marians KJ. The importance of repairing stalled replication forks. Nature 2000; 404: 37–41.
   PubMed Web of Science ®Google Scholar
• Radman M. Enzymes of evolutionary change. Nature 1999; 401: 866–9.
   PubMedGoogle Scholar
• Gerlach VL, Aravind L, Gotway G, Schultz RA, Koonin EV, Friedberg EC. Human and mouse homologs of Escherichia coli DinB (DNA polymerase IV), members of the UmuC/DinB superfamily. Proc Natl Acad Sci USA 1999; 96: 11922–7.
   PubMed Web of Science ®Google Scholar
• Colston MJ, Davis EO, Papavinasasundaram KG. General recombination. In: Hatfull GF, Jacobs WR Jr., eds. Molecular genetics of mycobacteria. Washington, D.C.: American Society for Microbiology Press, 2000: 85–91.
   Google Scholar
• Graham JE, Clark-Curtiss JE. Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS). Proc Natl Acad Sci USA 1999; 96: 11554–9.
   PubMed Web of Science ®Google Scholar
• Clements MO, Foster SJ. Stress resistance in Staphylococcus aureus. Trends Microbiol 1999; 7: 458–62.
   PubMedGoogle Scholar
• Friedberg E, Gerlach VL. Novel DNA polymerases offer clues to the molecular basis of mutagenesis. Cell 1999; 98: 413–6.
   PubMedGoogle Scholar
• Johnson RE, Washington MT, Prakash S, Prakash L. Bridging the gap: a family of novel DNA polymerases that replicate faulty DNA. Proc Natl Acad Sci USA 1999; 96: 12224–6.
   PubMed Web of Science ®Google Scholar
• Wagner J, Nohmi T. Escherichia coli DNA polymerase IV mutator activity: genetic requirements and mutational specificity. J Bacteriol 2000; 182: 4587–95.
   PubMedGoogle Scholar
• Karunakaran P, Davies J. Genetic antagonism and hypermutability in Mycobacterium smegmatis. J Bacteriol 2000; 182: 3331–5.
   PubMed Web of Science ®Google Scholar
• Lipsitch M, Levin BR. The within-host population dynamics of antibacterial chemotherapy: conditions for the evolution of resistance. Ciba Found Symp 1997; 207: 112–27.
   PubMedGoogle Scholar
• Lipsitch M, Levin BR. Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance. Int J Tuberc Lung Dis 1998; 2: 187–99.
   PubMed Web of Science ®Google Scholar
• Mitchison DA. How drug resistance emerges as a result of poor compliance during short-course chemotherapy for tuberculosis. Int J Tuberc Lung Dis 1998; 2: 10–15.
   PubMed Web of Science ®Google Scholar
• Barry CE III, Slayden RA, Sampson AE, Lee RE. Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs. Biochem Pharmacol 2000; 59: 221–31.
   PubMedGoogle Scholar
• Ramakrishnan L, Federspiel NA, Falkow S. Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 2000; 288: 1436–9.
   Google Scholar
• McDermott W, Tompsett R. Activation of pyrazinamide and nicotinamide in acidic environments in vitro. Am Rev Tuberc 1954; 70: 748–54.
   PubMedGoogle Scholar
• Cheng SJ, Thibert L, Sanchez T, Heifets L, Zhang Y. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Antimicrob Agents Chemother 2000; 44: 528–32.
   Google Scholar
• Brosch R, Gordon SV, Eiglmeier K, Garnier T, Tekaia F, Yeramian E, et al. Genomics, biology and evolution of the Mycobacterium tuberculosis complex. In: Hatfull GF, Jacobs WR Jr., eds. Molecular genetics of mycobacteria. Washington, D.C.: American Society for Microbiology Press, 2000: 19–36.
   Google Scholar
• Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393: 537–44.
   PubMed Web of Science ®Google Scholar
• Banu S, Honore N, Saint-Joanis B, Cole ST. Immunological studies of PE-PGRS proteins of Mycobacterium tuberculosis. In: Abstracts of the ASM Conference on Tuberculosis: Past, Present and Future, New York June 20–24. Washington, D.C.: American Society for Microbiology Press, 2000: Abstract 23.
   Google Scholar
• Supply P, Mazars E, Lesjeans S, Vincent V, Gicquel B, Locht C. Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol Microbiol 2000; 36: 762–71.
   PubMed Web of Science ®Google Scholar